Novel therapeutics could offer clinicians an additional tool in developing their patient treatment plans, particularly for those with no response or resistance to existing therapies.
IBD doesn't have a cure, and treatments are often limited. But, in recent years, gastrointestinal researchers have sharply focused on solutions for the disease overall and Crohn's in particular.
The recent guidance from AGA includes 12 best practices that address dietary options, enteral and parenteral nutrition, patient monitoring, and the need for multidisciplinary care.